Vertex Pharmaceuticals offers promising opportunities in pain management, cystic fibrosis treatments, and a diversified ...

In a report released yesterday, Gena Wang from Barclays reiterated a Buy rating on Sangamo Biosciences (SGMO – Research Report), with a price ...

Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...

GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

As we enter the new year, all eyes are on the biotech companies awaiting key FDA decisions in January. In 2024, the FDA approved 50 ...

America's pharmaceutical founding fathers Meanwhile in the USA, Pfizer was founded in 1849 by two German immigrants, initially as a fine chemicals business. Their business expanded rapidly during ...

The drug and biotech industry had a tough time in the past couple of months after Trump announced the appointment of Robert F ...

Realistic Expectations for 10 Disruptive Technologies in 2025 The new year is here, and 2025 has the potential to be one of the most exciting moments in a long time. Momentum continues to build around ...

This was the stock's third consecutive day of gains.

Shares of Vertex Pharmaceuticals Inc. VRTX inched 0.84% higher to $402.70 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.43 ...